dupilumab

Dupixent (dupilumab) is increasingly prescribed for treating moderate to severe eczema and asthma in children, but concerns arise about its interaction with live vaccines. While earlier studies recommended avoiding live vaccines due to its immune-modulating effects, recent reviews indicate that live vaccines are safe and effective for patients taking Dupixent.